Cytosorbents Corporation reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was USD 0.044931 million compared to USD 0.191468 million a year ago. Revenue was USD 8.81 million compared to USD 8.11 million a year ago. Net loss was USD 9.19 million compared to USD 12.2 million a year ago. Basic loss per share from continuing operations was USD 0.21 compared to USD 0.28 a year ago.
For the nine months, sales was USD 0.055285 million compared to USD 0.541694 million a year ago. Revenue was USD 27.68 million compared to USD 25.3 million a year ago. Net loss was USD 22.67 million compared to USD 32.05 million a year ago. Basic loss per share from continuing operations was USD 0.52 compared to USD 0.74 a year ago.